Skip to main content

Table 4 Summary of the response of 35 evaluated patients, divided into CR, PR, SD and PD.

From: Irinotecan plus folinic acid/continuous 5-fluorouracil as simplified bimonthly FOLFIRI regimen for first-line therapy of metastatic colorectal cancer

Response

No.(%)

Complete Response

4 (11)

Partial Response

7 (20)

Overall Response Rate (CR+PR)

11 (31)

Stable disease

15 (43)

Tumor control rate (CR+PR+SD)

26 (74)

Progressive disease

9 (26)